A marketplace helping therapists accept insurance and patients find in-network care goes after the two things that keep the most people out of therapy altogether.
Grow Therapy is a marketplace helping therapists accept insurance and patients find in-network care. Most therapy-access startups focus almost entirely on the patient side of the problem, better search, faster booking, more provider listings, while leaving the supply-side reason so many therapists don't accept insurance in the first place largely untouched. Grow Therapy's model is built around fixing both sides at once.
Fixing the therapist's side of the equation, not just the patient's
Most therapy-access startups focus entirely on patient-facing search. Grow Therapy also solves the harder, less visible problem: helping independent therapists actually navigate insurance credentialing and billing, which is often why they avoid accepting insurance in the first place. Credentialing and claims administration are notoriously time-consuming for a solo practitioner, and many therapists simply opt out of insurance entirely rather than absorb that administrative burden, which is precisely the burden Grow Therapy takes on for them.
Cost and access, not clinical quality, are consistently cited as the two single biggest barriers to therapy utilization, which is exactly the pair Grow Therapy is built to remove.
A two-sided marketplace fix for a two-sided problem
By making it administratively easier for therapists to accept insurance, Grow Therapy grows the supply of in-network care, not just the visibility of it. That's a structurally different, and arguably more durable, approach than a search-and-discovery platform alone, since a directory of therapists who don't accept insurance doesn't actually solve the access problem for most patients, it just makes the existing shortage easier to browse.
Supply growth as the real metric to track
Watch growth in the number of therapists newly accepting insurance through the platform, rather than just patient sign-ups, since supply-side growth is the harder and more defensible number in a two-sided marketplace like this one. Patient demand for affordable therapy is effectively unlimited relative to current supply, so the constraint that actually determines Grow Therapy's ceiling is how many therapists it can bring into the insurance system, not how many patients it can attract to browse a still-limited pool.
